Levels of the factor VII complex were found to be raised in patients with chronic renal failure and further raised by regular dialysis. Increased fibrinogen concentrations were also found. These results suggest the existence of a prothrombotic state in uraemia that is exacerbated by haemodialysis. Ristocetin-induced platelet agglutination, however, was depressed in uraemia and worsened by dialysis. This defect may be transferred to normal platelets from dialysed uraemic plasma, suggesting the existence of an inhibitor of the interaction between factor VIII and platelet glycoprotein.
Introduction
Despite the central role of factor VIII in haemostasis its biology is not yet fully elucidated.' It appears to be a complex consisting of factor VIII coagulant activity, factor VIII-related antigen, and factor VIII-von Willebrand factor (VIII vWf), which may be the same as the ristocetin cofactor. VIII vWf is antigenically related to factor VIII-related antigen, and may be a subunit of it that plays a part in ristocetin-induced platelet agglutination and the retention of platelets within glass-bead columns.2 Physiologically, VIII vWf appears to mediate the interaction between platelet-membrane glycoproteins and exposed collagen, and King temperature, to give a platelet count of 200-400 x 109/1. The change in optical density per minute was determined using a Born aggregometer (Albert Browne Ltd) with ristocetin (Lundbeck) at a final concentration of 15 mg/ml. In further studies ristocetin-induced aggregation was performed on unwashed normal platelets suspended at a final concentration of 200 x 109/l in platelet-poor plasma from patients with chronic uraemia or receiving regular dialysis. Aggregations were performed in duplicate with platelets from normal controls resuspended in their own plasma, the change in optical density so obtained being regarded as 100%. Results were analysed using paired and unpaired t tests and, when appropriate, the x2 test with Yates's correction.
Results
Factor VIII-Values of factor VIII-related antigen and coagulant activity were significantly higher than control values in both the patients receiving dialysis and those with uraemia (table I), but the ratio of factor VIII-related antigen to coagulant activity was higher in the patients receiving dialysis, as was the number of patients with a ratio of over 1-5. In those patients with chronic uraemia in whom serial samples were obtained until their establishment on regular dialysis (table II) there was a significant widening of the ratio, resulting mainly from lower values of factor VIII coagulant activity, consistent with increased consumption of this activity. Consequently, a Ristocetin-induced platelet agglutination-Uraemic patients, whether or not treated by dialysis, had significantly depressed rates of platelet by hypertension or hyperlipidaemia-may progress to atherosclerosis.21 That the factor VIII complex plays a part in mediating aterrial damage has been shown in animal experiments.22 Furthermore, the widened ratio of factor VIII-related antigen to VIII coagulant activity is a marker of intravascular coagulation,"3 as has been shown, for example, in pre-eclampsia. 23 We have previously shown that the potent antiplatelet agent prostacyclin not only prevents platelet activation and consumption during haemodialysis24 but also prevents the dialysisinduced rise in concentrations of antithrombin III that may result from release of antithrombin III from platelets and endothelium damaged by the extracorporeal circulation (J H Turney et al, paper in preparation). The results presented here show that values of factor VIII-related antigen also rise progressively during dialysis with heparin alone and that this rise is also prevented by administering prostacyclin. As VIII-related antigen is synthesised by both vascular endothelium25 and megakaryocytes26 the raised values in uraemia may result from long-term, low-grade endothelial damage and platelet activation, which are exacerbated by the extracorporeal circulation. This contention is supported by the ratio of factor VIII-related antigen to coagulant activity, which is widened in chronic renal failure and to an even greater extent during regular dialysis. Thus a vicious circle is created, with raised values of factor VIII, a marker of endothelial damage, providing the mechanism for both further vascular insult and intravascular coagulation, the situation being exacerbated by the reinfusion during haemodialysis of activated platelets, etc (figure). This study provides further support for the use of platelet-suppressive treatment in haemodialysis. 2' The increased concentrations of prostacyclin in uraemia may be the result of increased vascular synthesis4 resulting from sustained endothelial damage. The prostacyclin may provide some endothelial protection but, as a "trade-off",28 results in a prolonged bleeding time. Prolonged bleeding time may also result from either a deficiency of VIII vWf, asin von Willebrand's disease,29 or a defect of the platelet-membrane glycoproteins as in Bernard-Soulier disease.'0 " Our results suggest that uraemic platelets have a Bernard-Soulier-type defect of ristocetininduced agglutination in the presence of raised values of factor VIII, which can enhance the aggregation of normal platelets. In addition, there is a plasma inhibitor of the VIII vWf-platelet interaction in patients receiving dialysis, which we suggest is one or more of the uraemic "middle-molecule" toxins. The bleeding time in uraemic patients may be shortened by infusing cryoprecipitate," but, unlike in von Willebrand's disease, the improvement takes some hours to appear and is relatively short lived. The time course of the effect of cryoprecipitate is compatible with competition for the platelet glycoprotein 1B-receptor site between VIII vWf in cryoprecipitate and the abnormal uraemic VIII vWf or with a plasmatic factor that may alter the nature of or combine with, and therefore occlude, the receptor. The result of this defect of VIII vWf-mediated platelet adhesion is the characteristic uraemic bleeding diathesisnamely, decreased ristocetin-induced agglutination and platelet retention in glass-bead columns, and a prolonged bleeding time. As with Bernard-Soulier platelets, however, this defect does not necessarily affect the aggregation (as opposed to adhesion) of platelets to various stimuli including collagen, adenosine diphosphate, and thrombin.
The hypothesis derived from our studies of factor VIII in uraemia permits the reconciliation of uraemic bleeding with the reported accelerated atherogenesis in patients receiving dialysis.33 The prothrombotic state induced by uraemia and aggravated by dialysis results from and continues to exacerbate endothelial damage, the consequence of which may be atherosclerosis. Prostacyclin released in response to the endothelial damage may prolong the capillary bleeding time, which is also increased by an acquired defect in function of the factor VIII vWf.
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Introduction
Over the past 14 years we have studied identical twin pairs in whom one or both were diabetic. Of the 200 pairs seen to date, 147 were insulin-dependent and 53 non-insulin-dependent diabetics. Of the 53 non-insulin-dependent pairs, all but five were concordant-that is, both twins were diabetic; in contrast, among the insulin-dependent pairs only about half were concordant. In the five discordant non-insulin-dependent pairs the diabetic twin had been diagnosed only within the past three years, whereas the interval between diagnosis of diabetes in the first and second twins of the 48 concordant pairs in no case exceeded seven years. Hence it seemed likely that the five so
